GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SS Innovations International Inc (OTCPK:SSII) » Definitions » Enterprise Value

SS Innovations International (SS Innovations International) Enterprise Value : $692.79 Mil (As of Jun. 09, 2024)


View and export this data going back to 2018. Start your Free Trial

What is SS Innovations International Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, SS Innovations International's Enterprise Value is $692.79 Mil. SS Innovations International's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-22.13 Mil. Therefore, SS Innovations International's EV-to-EBIT ratio for today is -31.31.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, SS Innovations International's Enterprise Value is $692.79 Mil. SS Innovations International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-21.74 Mil. Therefore, SS Innovations International's EV-to-EBITDA ratio for today is -31.87.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, SS Innovations International's Enterprise Value is $692.79 Mil. SS Innovations International's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $11.22 Mil. Therefore, SS Innovations International's EV-to-Revenue ratio for today is 61.75.


SS Innovations International Enterprise Value Historical Data

The historical data trend for SS Innovations International's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SS Innovations International Enterprise Value Chart

SS Innovations International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial 22.29 11.51 -0.23 63.17 1,243.86

SS Innovations International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.91 2,271.43 2,069.51 1,243.86 1,034.27

Competitive Comparison of SS Innovations International's Enterprise Value

For the Medical Devices subindustry, SS Innovations International's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SS Innovations International's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's Enterprise Value distribution charts can be found below:

* The bar in red indicates where SS Innovations International's Enterprise Value falls into.



SS Innovations International Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

SS Innovations International's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

SS Innovations International's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SS Innovations International  (OTCPK:SSII) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

SS Innovations International's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=692.794/-22.127
=-31.31

SS Innovations International's current Enterprise Value is $692.79 Mil.
SS Innovations International's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-22.13 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

SS Innovations International's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=692.794/-21.741
=-31.87

SS Innovations International's current Enterprise Value is $692.79 Mil.
SS Innovations International's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-21.74 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

SS Innovations International's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=692.794/11.219
=61.75

SS Innovations International's current Enterprise Value is $692.79 Mil.
SS Innovations International's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SS Innovations International Enterprise Value Related Terms

Thank you for viewing the detailed overview of SS Innovations International's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


SS Innovations International (SS Innovations International) Business Description

Traded in Other Exchanges
N/A
Address
1500 SE 15th Street, Suite 512, Fort Lauderdale, FL, USA, 33316
SS Innovations International Inc, formerly Avra Medical Robotics Inc develops medical-surgical devices. It invests in four areas including surgical robotic systems, surgical tools, implantable devices, and surgical robotic training. It is a medical robotics company developing a fully autonomous medical robotic system using proprietary software which integrates Artificial Intelligence and Deep Learning, or machine learning. By using an AI and DL-enhanced software program, the company is creating an intelligent robotic system that it believes can robotize a wide range of medical procedures currently being performed by human hands.
Executives
Barry F Cohen director, officer: COO 1600 SOUTHEAST 15TH STREET, APT 512, FORT LAUDERDALE FL 33316
Sudhir Srivastava director, 10 percent owner, officer: Chairman and CEO C/O AVRA SURGICAL ROBOTICS, ONE LIBERTY PLAZA, 35TH FLOOR, NEW YORK NY 10006
Kumar Sethi Anup officer: Chief Financial Officer C-102, DREAM APARTMENTS,, PLOT-14, SECTOR 22, DWARKA, NEW DEHLI K7 110077
Pascual Srivastava Vishwajyoti officer: President 28 HAARBAA, TRIAVENI GARDENS COMPLEX, GADAIPUR MEHRA, NEW DEHLI K7 110030
Sampige Prasannakumar Somashekar director APT 9J, NEST NO 8, 303 LG HALFI, RMV II, BANGALORE K7 560094
Annadurai Mylswamy director #344, NTI LAYOUT, 10TH MAIN, VIDHYARANYAPURA, BANGALORE K7 560067